Free Newsletter
Survey: Doctors still like gifts from pharma
The public, medical schools, and state governments may have begun to raise a collective eyebrow at drugmakers' gift-giving to doctors, and the companies themselves have begun to acknowledge the perception that it creates conflicts of interest. But individual doctors still kind of like it. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: